Medical Affairs Executive Forum and the
13th Investigator-Initiated Trials Conference for Maximum Learning and Networking Opportunities!
Tri-Located with ExL Pharma’s
THE BUSINESS OF SCIENCEHoning MSL Business Acumen and Expertise to Drive Long-Term Corporate Sustainability and SuccessRALPH REWERS, PharmD, Executive Director and Head Regional Medical Liaisons,Scientific Affairs, AMGEN
INTERACTIVE SESSION: METRICS FOR MSLSWhere Are We Now and Where Are We Going?PETER PILIERO, MD, Executive Director and Medical Leader, BOEHRINGER INGELHEIM
MSLS AND CLINICAL TRIALSOutlining the Challenges and Opportunities for MSLs to Support the Successful Execution of Investigator-Initiated Trials and Company-Sponsored TrialsANNA KOZLOVSKI, PharmD, Associate Medical Director, Lymphoma Team Lead, EISAI
PRE-CONFERENCE WORKSHOP A:
MSL AND MEDICAL AFFAIRS COLLABORATIONImproving Internal Communication between Field-Based MSLs and Office-Based Medical Affairs to Strengthen Scientific Integrity and Therapeutic Area SuccessPAUL WEBER, MD, RPh, MBA, Executive Director, Global Medical Affairs, Medical Disease Lead, CELGENE
PRE-CONFERENCE WORKSHOP B:
MSL TRAINING STANDARDSDeveloping the Skills and Core Competencies of MSLs to Enhance Team PerformancePAUL MINNE, PharmD, RPH, Senior Regional Medical Liaison Metabolic Bone, AMGENDENISE PITNER, PharmD, Therapeutic Team Director, NOVARTISCRAIG KLINGER, RPh, Senior Medical Liaison Consultant, ELI LILLY & CO.
DISTINGUISHED SPEAKERS
JOIN US FROM:
ACTELION PHARMACEUTICALS, US
AMGEN
BAYER HEALTHCARE
BOEHRINGER INGELHEIM
CELGENE
ELI LILLY & CO.
EISAI
GENZYME
IKARIA
MCGUIREWOODS
NOVARTIS
OPENQ
SHIRE
WITHIN3
ZIPHER MEDICAL AFFAIRS, LLC
SPONSORED BY:
A P R I L 1 4 - 1 5 , 2 0 1 1 | D O L C E | B A S K I N G R I D G E | N E W J E R S E Y
8th MSL BEST PRACTICES
To Register Cal l 866-207- 6528 or Vis it www.exlpharma.com/8thmsl
WHO SHOULD ATTEND?Professionals from Pharmaceutical,
Biotechnology and Medical Device
companies with responsibilities in the
following areas:
• Medical Science Liaisons (MSLs, MLs)
• Medical Affairs
• Medical Communications
• Scientific Affairs
• Medical Advisors/Managers
• Clinical Trial Liaisons
• KOL Development
• Clinical Research
• Medical Education
• Clinical/Outcomes Liaisons
• Clinical Investigators
• Business Intelligence
• Regulatory Affairs
This conference is also of interest to:
• Software and Technology Companies
• Staffing Agencies/Recruiters
• Law Firms
• Consultants
DOLCE BASKING RIDGE300 NORTH MAPLE AVE BASKING RIDGE, NJ 07920
PHONE: 800-953-8033
FAX: 908-953-3105
Dolce Basking Ridge combines a retreat-like setting with over 20,000 square feet of IACC approved function space. The award-winning Dolce Basking Ridge is the Tri-state region’s setting of choice for business and pleasure. A recent multi-million dollar redesign has updated our accommodations, restaurantand lobby to have the chic and contemporary feel of New York City while maintaining the quiet seclusion of Basking Ridge.
Dolce Basking Ridge is less than an hour west of Manhattan from Interstate 287, 78 and 80.
Newark Liberty Airport is approximately a 30-minute drive, while LaGuardia and JFK Airports are just an hour away.
Shuttle Information: We offer Complimentary shuttle service within a 6 mile radius which includes the Basking Ridge Train Station.
Airport Information: Newark International Airport is approximately 30 minutes away.
Please contact the hotel directly at 800-953-8033 to book your room. Please mention ExL Pharma and the 8th MSL Best Practices conference to take advantage of this discount. You must book your room by March 23, 2011 to be eligible for the discounted rate. Please book your room early as the rooms available at this rate are limited and review your hotel confirmation to ensure that you received the ExL group rate.
“I was really impressed with virtually everything about this event. The topics were right on target, the speakers were great, having lots of time for questions and interactive discussions was perfect.”
– MEDICAL SCIENTIFIC MANAGER | ALLERGAN
Dear Colleague,As the healthcare landscape in the United States continues to change, the role of the Medical Science Liaison (MSL) is growing in relevance and importance. Stricter regulations, increased competition, and shrinking pipelines are contributing to higher stakes and the need for pharmaceutical, biotech and medical device companies to have effective MSL teams in place. The education and product awareness that MSLs bring to thought leaders and the broader medical community are essential to corporate sustainability and success. Further, the peer-to-peer relationships that MSLs initiate and maintain with KOLs and the field insights they bring back to the company are fundamental, particularly as sales forces are being reduced throughout the nation. The strong business acumen, communication skills, and therapeutic area expertise that MSLs possess are tools that are tremendously meaningful, and when channeled properly, can be enormously valuable to both internal and external stakeholders.
Building from the success of seven previous events, ExL Pharma’s 8th MSL Best Practices is designed to provide attendees with information on the latest trends, changes, and best practices for MSLs operating in such a complex environment. Attending this event provides exciting opportunities for networking with industry colleagues and benchmarking activities, strategies and goals. The expert speaking faculty and highly informative topics help MSLs effectively meet the needs of internal and external customers, while remaining professionally fulfilled.
We look forward to greeting you in April!
Sincerely,
Lindsay Slater Senior Conference Director 8th MSL Best Practices
“Exceeded my expectations” - MSL | TERCICA “Excellent seminar…will attend in the future” – MSL | MILLENNIUM
To Register Cal l 866-207- 6528 or Vis it www.exlpharma.com/8thmsl
PRE-CONFERENCE WORKSHOP | DAY ONE THURSDAY, APRIL 14
8:00 REGISTRATION AND CONTINENTAL BREAKFAST FOR WORKSHOP PARTICIPANTS
9:00 PRE-CONFERENCE WORKSHOP A: MSL AND MEDICAL AFFAIRS COLLABORATION Improving Internal Communication between Field-Based MSLs and Office-Based Medical Affairs to Strengthen Scientific Integrity and Therapeutic Area Success
• Definingexpectationstooptimizethecollaborationbetweenhomeofficeandfieldbasedteams
• UnderstandinghowMSLscaneffectivelyconveyimportantfieldmedicalinsightstoinformandpotentiallychangetheactivitiesofinternalMedicalAffairscolleagues
• Realizingthevalueofoffice-basedMedicalAffairsinsettingstrategy• SharingbestpracticesespeciallyregardingKOLinteractionsformaintainingthe
balanceofroles,responsibilities,andrelationshipsoffunctionalgroupswithinMedicalAffairs
• Leveragingthebenefitsofincreasedcommunicationandtransparency
* Thisworkshopwillbehighlyparticipatoryforattendees.Itsdesignwillincludebreakoutgroupsandreporting.Paul Weber, MD, RPh, MBA, Executive Director, Global Medical Affairs, Medical Disease Lead, CELGENE
10:30 NETWORKING & REFRESHMENT BREAK
12:00 WORKSHOP CONCLUDES; LUNCHEON FOR WORKSHOP PARTICIPANTS
9:00 PRE-CONFERENCE WORKSHOP B: MSL TRAINING STANDARDS Developing the Skills and Core Competencies of MSLs to Enhance Team Performance
• IdentifyingthekeyattributesessentialfortheMSLrole• Howcaninterpersonalskillsbeimproved,ifatall?• Weighingeducationandexperience–istherean“ideal”combination?Isone
moreimportantthantheother?• StrikingtherightcombinationofstrengthsacrossanMSLteam• Hiringatrainerandoutliningtherolesandresponsibilitiesoftheposition• Buildinginassessmenttoolsinhiringcriteria• MeasuringthesuccessofMSLtraininginitiatives
Paul Minne, PharmD, Senior Regional Medical Liaison, AMGEN Denise Pitner, PharmD, Therapeutic Team Director, NOVARTIS Craig Klinger, RPh, Senior Medical Liaison Consultant, ELI LILLY & CO.10:30 NETWORKING & REFRESHMENT BREAK
12:00 WORKSHOP CONCLUDES; LUNCHEON FOR WORKSHOP PARTICIPANTS
MAIN CONFERENCE BEGINS | DAY ONE
1:00 CHAIRPERSON’S WELCOME AND OPENING REMARKS Hilary D. Mandler, PharmD, Director, ADHD Medical Science Liaisons, SHIRE
1:15 THE BUSINESS OF SCIENCE
Honing MSL Business Acumen and Expertise to Drive Long-Term Corporate Sustainability and Success
• Exploringthepotentialoffield-basedmedicaltocompliantlystrengthenexistingrelationships,forgenewpartnershipsandserveaskeyplayersinstrategicplanninganddevelopment
• Acquiringandsynthesizingfieldinsightstodriveclinicalandcorporatedecision-making
• DemonstratingvalueoftheexpensiveMSLpositiontothecompany• Providingmaximumvaluetointernalteamsandexternalpartnersthrough
establishedcredibilityandexpertise Ralph Rewers, PharmD, Executive Director and Head Regional Medical Liaisons, Scientific Affairs, AMGEN
2:00 INTERACTIVE SESSION: METRICS FOR MSLS
Where Are We Now and Where Are We Going?
• Benchmarkingdata:whatistheindustrydoing?• Establishinggoalsandmeasuringperformancefordemonstratingvalueand
maximizingresults• Selectingcompliantmetricsthataremeaningfultomanagementandacceptedby
theMSLteam• Balancingqualitativeandquantitativemetricsthatreflectvaluetointernal
stakeholdersandexternalcustomers• Leveragingmetricsforteammotivationandmorale
Peter Piliero, MD, Executive Director & Medical Leader, BOEHRINGER INGELHEIM
2:45 NETWORKING AND REFRESHMENT BREAK
3:15 CASE STUDY
Maximizing MSL Productivity and Compliance through the Development of a Monthly Activity Reporting System
• Utilizingareportingsystemtostrengthencompliancewithinternalpoliciesandproceduresaswellasindustry-wideregulatoryrequirements
• Consideringthe“how,”the“why,”andthe“whyimportant”ofamonthlyactivityreportingsystemforMSLteams
• IncreasingcommunicationandtransparencybetweenMSLsandtheirmanageronactivities,reporting,andgoaltracking
• Exploringthebenefitsofimplementingatoolthatshowsresourceallocationandtheneedforexpansion,asitcantrackandreportontimeperactivity(perday,week,month,year)
• OptimizinginternalcommunicationtostrengthenMSL-KOLinteractions Peter L. Goldberg, PhD, Associate Director, Medical Science Liaisons, ACTELION PHARMACEUTICALS, US
4:00 FIELDING A WINNING TEAM Empowering MSLs to Maximize Your Return on Investment (ROI)
• DefiningasuccessfulMSLteam;reviewexamplesofMSLprogramsandanalyzingstrengthsandweaknessesinordertodemonstratesubtledifferencesbetweenagoodandanoutstandingMSLorganization
• Exploringtheroleseducation,decisionmakingandcommunicationplayinenhancingMSLperformance
• OutliningthetechniquesandsystemsthatcanbeimplementedtoimproveMSLperformance
• Discussingtheimportanceofdebriefing,measuringsuccessandhowKOLsreacttoempoweredMSLs
• Usinginternalcommunicationstodemonstratevalue Peg Crowley-Nowick, PhD, MBA, Founder and President, ZIPHER MEDICAL AFFAIRS, LLC
To Register Cal l 866-207- 6528 or Vis it www.exlpharma.com/8thmsl
4:45 COCKTAIL RECEPTION & ROUNDTABLE
DISCUSSIONS
CHOOSE YOUR PREFERRED TOPIC AND DISCUSS
IN AN INTIMATE, BREAK-OUT STYLE, SETTING.1. Team Size and Design:HowcanmyteambestallocateMSLs,resourcesand
activities?2. Aggregate Spend and Reporting Requirements:Howwill/arestateand
federaldisclosurelawsimpactingphysician-industryrelationships,andhowcanIensurethatmyinteractionswithHCPsarecompliant?
3. National KOLs:Whatarebestpracticesforidentifying,buildingandleveragingrelationshipswithnationalthoughtleaders?
4. MSL Team Management:Whatcanandshouldmanagersbedoingtoensurecohesive,motivatedandeffectiveteams?
5. Off-Label Information Dissemination:HowcanMSLsmitigateriskofviolatinglaws,rulesandcompanypolicieswhenrespondingtounsolicitedrequests?
6. Professional and Personal Development:WhatopportunitiesareavailableandhowcanMSLsmaintainfeelingfulfilledwhileintheircurrentpositionsandlookingtothefuture?
6:00 CLOSE OF DAY ONE
MAIN CONFERENCE | DAY TWOFRIDAY, APRIL 15
8:00 CONTINENTAL BREAKFAST FOR CONFERENCE PARTICIPANTS
8:45 CHAIRPERSON’S RECAP OF DAY ONE AND MODERATORS’ KEY POINTS FROM ROUNDTABLE DISCUSSIONS Hilary D. Mandler, PharmD, Director, ADHD Medical Science Liaisons, SHIRE
9:00 REGULATORY OVERVIEW Sunshine Provisions, Corporate Integrity Agreements, DOJ Investigations, Oh My!
• Outliningthe“SunshineAct”provisionsandtheirimpactonMSLactivities• DiscussingFDA/OIGconcernsaboutoff-labelpromotion• Exploringillustrativestatereportingrequirementsandrestrictionsonindustry-KOL
interactions• Examiningtheprevalenceofcorporateintegrityagreementsandtheireffecton
theMSLrole• Strategiestodecreasetheriskthatindividual,teamorcompanycouldbeaccused
ofviolations Joseph P. McMenamin, MD, JD, Partner, MCGUIREWOODS
10:00 COMPLIANT MSL-KOL ENGAGEMENT Regulatory and Technological Trends for 2011
•CompliantqualificationofKOLs•Techniquesforplanning,executing,andmeasuringanMSL/KOLstrategy•Gatheringfieldinsightsthroughresponsiveinquiry•Analyticsforensuringtheregulatorycomplianceandoperatingeffectivenessof
yourprograms Jim Zuffoletti, President and Co-Founder, OPENQ
10:45 NETWORKING AND REFRESHMENT BREAK
11:15 PANEL DISCUSSION: BREAKING DOWN SILOS Increasing Compliant Collaboration with Sales for Improved Transparency, Efficiency, and KOL Management
• Determiningthetypesofcommunicationthatareappropriateandbeneficial,andestablishingacompliantprocessforcross-functionalinteractions
• Exploringbestpracticesfordocumentinginformationexchangedbetweeninternaldepartments
• Overcomingbarrierstoworkingwithsalesanddemonstratingvaluetoyourcommercialcolleagues
• Realizingthepositivebusinessoutcomesofcompliantandcontrolledcommunicationacrossteams
Panelists: Douglas Werner, MBA, National Director, Oncology, Medical Science Liaisons, U.S. Medical Sciences, BAYER HEALTHCARE Ralph Rewers, PharmD, Executive Director and Head Regional Medical Liaisons, Scientific Affairs, AMGEN Cindy Sellers O’Brien, RN, BSN, MBA, Director, Medical Science Liaison Team–Solid Organ Transplant, GENZYME TRANSPLANT AND ONCOLOGY
12:00 DIGITAL KOL ENGAGEMENT Creating an Online Forum to Dramatically Increase Interactions with Important KOLs
Inthissession,participantswilllearnhowengaginginaprivate,onlinecommunitycan:• GalvanizerelationshipsandenhanceKOLinteractions• Providevaluableinsightsaswellascompletevisibilityintotherapeuticdiscussions• EnablemorefrequentHCPinteractionona24/7basisdespitegeographic
locations• FosteremergingKOLs
•ExpandreachandinteractionswithglobalKOLleaders Lance Hill, CEO, WITHIN3
12:45 LUNCHEON FOR CONFERENCE PARTICIPANTS
1:45 MSLS AND CLINICAL TRIALS
Outlining the Challenges and Opportunities for MSLs to Support the Successful Execution of Investigator- Initiated Trials and Company-Sponsored Trials
• EnhancingtherelationshipbetweenR&DandMedicalAffairstosupportefficienttrialimplementation
• ExploringtheidealapprovalflowofIITsfromMSLdiscussionofideaswithinvestigatorstodialoguewithregionalteams
• DetermininghowtheMSLcanhelpensurethattimelinesarebeingadheredtoandmilestonesarebeingmet
• EstablishingtherightlevelofMSLinvolvement,ifany,instudydesign,protocolandconduct
Anna Kozlovski, PharmD, Associate Medical Director, Lymphoma Team Lead, EISAI
2:30 LEADING FROM BELOW
How to Provide Leadership (and Increase One’s Value) within an Organization
Uponcompletionofthissessiontheattendeewillbeableto:• Describethedifferencebetweenamanagerandaleader• Recognizethequalitiescommontoleaders• Understandtheimportanceofleadersoninfluencingchangeandimproved
organizations• Developafoundationforacquiringthebehaviorsneededtoeffectivelyleadfrom
below Douglas Hansell, MSOM, RRT, Medical Science Liaison, IKARIA
3:15 CONFERENCE CONCLUDES
FIVE WAYS TO REGISTER PHONE: 866-207-6528
EMAIL: [email protected]
ONLINE: www.exlpharma.com
FAX: 888-221-6750
MAIL: ExL Events, Inc. 555 8th Ave, Ste 310 New York, NY 10018
GROUP DISCOUNT PROGRAM:
SAVE 25% PER PERSON WHEN REGISTERING FOUR For every three simultaneous registrations from your company, you will receive a fourth complimentary registration to the program (must register 4 at one time). This is a savings of 25% per person.
SAVE 15% PER PERSON WHEN REGISTERING THREE Can only send three? You can still save 15% off of every registration. To find out more on how you can take advantage of these group discounts, please call 866-207-6528.
Make checks payable to ExL Events, Inc. and write code P1123 on your check. You may also use Visa, MasterCard, Discover or American Express. Payments must be received in full prior to the commencement of the conference.
Cancellations: If you need to cancel your registration for an upcoming ExL conference, please note the following policies derived from the Start Date of the event:Four weeks or more: A full refund (minus a $95 processing fee), or a voucher to another ExL event valid for two years from the voucher issue date.Four weeks or Less: A voucher to another ExL event valid for two years from the voucher issue date.*ExLPharma’sliabilityislimitedtotheconferenceregistrationfeeintheeventofacancellation
To receive a refund or voucher, please fax your request to 888-221-6750.
Please Note: Conference registrations may betransferred to other colleagues in the event you are unable to attend. There will be an administrative charge of $300 to substitute, exchange and/or replace attendance badges with a colleague occurring within five business days of any ExL conference.Please notify ExL Pharma, [email protected], prior to the event with the name and contact information of the replacement attendee.
PleaseNote:Speakersandagendaaresubjecttochangewithoutnotice.Intheeventofaspeakercancellation,everyefforttofindasuitablereplacementwillbemade.*TheopinionsofthisfacultydonotnecessarilyreflectthoseofthecompaniestheyrepresentorExLEvents,Inc.*
Do you want to spread the word about your organization’s solutions and services to potential clients who will be attending this event? Take advantage of the opportunity to exhibit, present an educational session, host a networking event, or distribute promotional items to attendees. ExL Pharma will work closely with you to customize a package that will suit all of your needs. To learn more about these opportunities, please contact:
STEVE DECKER
Business Development Manager
212-400-6234, [email protected]
REGISTRATION FEES FOR ATTENDING ExL’S 8th MSL Best Practices Conference
EARLY BIRD PRICINGREGISTER BY FRIDAY, FEBRUARY 25, 2011 FOR EARLY-BIRD PRICING:
CONFERENCE + WORKSHOP | $1995
CONFERENCE ONLY | $1695
STANDARD PRICINGREGISTER AFTER FRIDAY, FEBRUARY 25, 2011:
CONFERENCE + WORKSHOP | $2195
CONFERENCE ONLY | $1895
ONSITE PRICING CONFERENCE + WORKSHOP | $2295
CONFERENCE ONLY | $1995
36OPMTHE FULL SPECTRUM OF PRODUCT MANAGEMENT
36O
MEDIA PARTNERS
SPONSORSHIP & EXHIBITING OPPORTUNITIES
PRE-CONFERENCE WORKSHOP A:
MSL AND MEDICAL AFFAIRS COLLABORATIONImproving Internal Communication between Field-Based MSLs and Office-Based Medical Affairs to Strengthen Scientific Integrity and Therapeutic Area SuccessPAUL WEBER, MD, RPh, MBA, Executive Director, Global Medical Affairs, Medical Disease Lead, CELGENE
PRE-CONFERENCE WORKSHOP B:
MSL TRAINING STANDARDSDeveloping the Skills and Core Competencies of MSLs to Enhance Team PerformancePAUL MINNE, PharmD, RPH, Senior Regional Medical Liaison Metabolic Bone, AMGENDENISE PITNER, PharmD, Therapeutic Team Director, NOVARTISCRAIG KLINGER, RPh, Senior Medical Liaison Consultant, ELI LILLY & CO.
DISTINGUISHED SPEAKERS JOIN US FROM:
A P R I L 1 4 - 1 5 , 2 0 1 1 | D O L C E | B A S K I N G R I D G E | N E W J E R S E Y
8th MSL BEST PRACTICES
ACTELION PHARMACEUTICALS, US
AMGEN
BAYER HEALTHCARE
BOEHRINGER
INGELHEIM
CELGENE
ELI LILLY & CO.
EISAI
GENZYME
IKARIA
MCGUIREWOODS
NOVARTIS
OPENQ
SHIRE
WITHIN3
ZIPHER MEDICAL AFFAIRS, LLC
SPONSORED BY:
REGISTER TODAY . . . www.exlpharma.com/8thmslMENTION PRIORITY CODE P1123
ExL Events, Inc.555 8th Avenue, Suite 310New York, NY 10018
866-207-6528
888-221-6750
www.exlpharma.com/8thmsl
Yes! Register me for the conference and workshop A Yes! Register me for the conference and workshop B
Yes! Register me for the conference only
Please contact me: I’m interested in marketing opportunities at this event I wish to receive email updates on ExL Pharma’s upcoming events
Name: Title:
Company:
Dept.:
Address:
City: State: Zip:
Email:
Telephone: Fax:
Method of Payment: Check Credit Card Make checks payable to ExL Events, Inc.Card Type: MasterCard Visa Discover Amex
Card Number: Exp. Date:
Name on Card:
Signature:
555 8th Avenue, Suite 310New York, NY 10018PRIORITY CODE: P1123
Top Related